MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MoonLake Immunotherapeutics (MLTX) Ownership - Who owns MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more
Profile
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.5B
P/E Ratio
N/A
Total Cash
448.03M
Projected Growth
N/A
Total Debt
2.83M
Revenue
N/A
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash/Share
7.08
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLTX
Capitalization
2.5B
P/E Ratio
N/A
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash
448M
Total Cash/Share
7.08
Total Debt
2.83M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
447M
P/B Ratio
5.61
Cash Flow
N/A
Earnings
-1.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.39K
Current Ratio
21.11
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-141.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.68
Shares Held By Institutions
5.83B
Shares Outstanding - Current
63.3M
Total Liabilities
24.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.036
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com